Phenogen Sciences, Inc. [www.phenogensciences.com] today announced the immediate availability of BREVAGen™, a predictive risk test for the millions of women at above average risk of developing estrogen-receptor positive breast cancer. This first-in-class, scientifically-validated risk assessment test examines a woman’s clinical risk factors, such as her lifetime exposure to estrogen, combined with scientifically validated genetic markers to determine each patient’s personalized five-year and lifetime risk of developing breast cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58399-phenogen-sciences-brevagen-breast-cancer-risk-assessment-test-availability
Friends since 1988, Sheryl Crow and Melissa Etheridge have endured their share of hardships—bad breakups, depression and for Etheridge, the anxiety around coming out sexually. But they fought their toughest battle when, within two years of each other, Crow and Etheridge each received a breast cancer diagnosis, shaking their worlds to the core. Through sheer determination and perseverance, they came out the other side. Now healthy and happy, the two survivors sat down with AARP The Magazine to discuss what they've learned and how they've each found a renewed sense of self.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7334451-aarp-the-magazine-music-legends-sheryl-crow-and-melissa-etheridge-talk-about-beating-cancer/
Today on Rare Disease Day, My Life, Our Future, a national program founded by leaders in the bleeding disorder community, including Bloodworks Northwest, the American Thrombosis and Hemostasis Network, the National Hemophilia Foundation and Bioverativ Inc., opened the largest research repository of its kind in the world to scientists. The My Life, Our Future Research Repository is a collection of genetic data and blood samples that are linked to phenotypic data from more than 5,000 people in the U.S. with hemophilia, a rare disorder that impairs the ability of one’s blood to clot. The My Life, Our Future Research Repository will allow researchers to advance the scientific understanding of the disorder, including genetic differences that affect bleeding severity and reaction to certain treatments.
To view the multimedia release go to:
https://www.multivu.com/players/English/8046151-national-hemophilia-foundation-my-life-our-future/
Ethicon* joins world-renowned experts in bariatric surgery to share the latest breakthroughs in science and innovation that are advancing surgery in the fight against obesity and metabolic diseases during ObesityWeek 2016, the combined annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS). Ethicon will highlight the growing body of research and evidence on the benefits of bariatric surgery, a new sleeve gastrectomy training module on the Touch Surgery app, and its comprehensive portfolio of bariatric surgery products aimed to improve patient outcomes.
“Ethicon’s mission is to lead the way in resolving the burden of obesity for both patients and healthcare systems by expanding access to care and demonstrating the critical value of treatment through research and evidence, while also enabling new technologies,” said Dr. Elliott Fegelman, Therapeutic Area Expert, Metabolics, Johnson & Johnson Innovation.
To view the multimedia release go to:
http://www.multivu.com/players/English/7965651-ethicon-bariatric-surgery-access-obesity-week-2016/
An estimated 48 million people in the United States have hearing loss, yet only 20 percent of people who could benefit from a hearing aid wear one. Cost is a major barrier as the average price of a hearing aid is $1,500 per ear, and can run as high as $3,000-$5,000 each. With the introduction of HearTEK™ Leasing from EPIC Hearing Healthcare (EPIC), individuals with hearing loss now have access to the latest name brand hearing aid technology without the barrier of huge upfront costs and with the peace of mind that they will not be locked into out-of-date technology.
“Consumers have gotten used to many of the benefits of leasing their smartphones – no one wants to pay upfront for technology that could be quickly outdated as hearing aid manufacturers regularly introduce new devices with updated features,” said Brad Volkmer, president and CEO, EPIC Hearing Healthcare. “The HearTEK Leasing program is an affordable new way to give more people with hearing loss access to quality hearing aid technology, so they can start hearing life to the fullest.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7808551-epic-heartek-leasing-hearing-aid/
The American Lung Association launched its first nationwide public service advertising (PSA) brand campaign in more than a decade today in an effort to raise awareness and engage people in the mission of the century-old public health charity. The campaign includes television, radio, print and out-of-home elements, all of which emphasize the American Lung Association’s brand platform and tagline, “Fighting for Air.”
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/lungusa/42818/
Professor Lionel Tarassenko, CBE, Head of Engineering at the University of Oxford and Fellow of the Royal Academy of Engineering and the Academy of Medical Sciences, has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
As the worlds of science and technology come together, the 2015 Astellas Innovation Debate, organised and funded by Astellas, will discuss recent breakthroughs in genetic medicine and smart technology, and what they mean for our health.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7432051-lionel-tarassenko-astellas-debate/
The National Bone Health Alliance (NBHA), a public-private partnership with 42 member organizations, is urging a simple solution to a big problem: if it’s 50+ fracture, request a test. This is the call-to-action for the NBHA’s new public and healthcare professional education campaign – 2Million2Many (www.2Million2Many.org).
The campaign reflects the two million bone breaks that occur in the U.S. each year that are caused by osteoporosis and urges the public and healthcare professionals alike to take action and request a test for osteoporosis when someone age 50 or older breaks a bone. Despite the fact that 50 percent of osteoporosis-related repeat fractures can be prevented with existing treatments, only two in 10 initial bone breaks get a follow-up test or treatment for osteoporosis.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56192-national-bone-health-alliance-nbha-prevent-osteoporosis-2million2many
23andMe, working in collaboration with the Milken Institute and Lundbeck, today announced that they have commenced enrollment for a first-of-its kind genetic study designed to gain understanding of the underlying biology of major depressive and bipolar disorders. This study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes – such as attention, decision-making and visual perception – in individuals who live with these serious mental health conditions.
“We know genetics play a role in the development of depression and bipolar, however there is a long pathway from our genes to the manifestation of complex diseases like these,” said Emily Drabant Conley, PhD., Vice President of Business Development at 23andMe. “We need to look at these conditions in a more comprehensive way to advance our understanding. By studying cognitive function alongside genetics and other environmental variables on a massive scale, we hope to take a significant step forward in the study of depression and bipolar.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8150951-23andme-genetic-study-depression-bipolar-disorders/
GSK Consumer Healthcare and FLONASE® Sensimist™ Allergy Relief, along with Emmy® Award-winning choreographer and entertainer Derek Hough, today announced the launch of the 2017 Greater American Road Trip featuring social media’s favorite family, the Eh Bees. On Thursday, March 16, the Eh Bee family will begin their coast-to-coast journey to rethink allergy treatment and leave each city a little bit greater than they found it.
Derek, along with Eh Bee family members Mama Bee and her son Mr. Monkey, all suffer from allergies, but are determined to be greater than their itchy, watery eyesi and congested noses with the help of new FLONASE Sensimist. After kicking off the journey together in Los Angeles, Derek will challenge the Eh Bees and their allergies as they partner with local organizations throughout some of the worst allergy cities in the country.
To view the multimedia release go to:
https://www.multivu.com/players/English/8061451-flonase-greater-american-road-trip-derek-hough-eh-bee/
Columbus businessman Scott Ressmeyer and 11 friends have started their 2013 Scott’s Ride for Miracles, a 21-day, 9,000-mile, 48-state motorcycle trek to raise awareness and money to benefit Children’s Miracle Network at The Medical Center in Columbus, Ga. The Miracle Send-Off Ceremony was held at 11:30 a.m. Friday morning, then at noon, the riders revved up their Harley engines and roared out of The Medical Center.
To view Multimedia News Release, go to http://www.multivu.com/players/English/61569-columbus-regional-healthcare-system-scotts-ride-for-miracles
Today, Johnson & Johnson, the world’s largest healthcare company, launches Johnson & Johnson Our Story at the Powerhouse and Johnson & Johnson Our Story to take visitors on a journey through time and around the world as they explore the stories behind more than 130 years of innovations that have changed the course of human health.
To view the multimedia release go to:
https://www.multivu.com/players/English/8077331-jnj-our-story/
